KABAKOFF DAVID S
SEC insider (Form 3/4/5 filer). CIK 0001024008. Director at NextCure, Inc. (NXTC). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in BELTSVILLE, MD.
Companies KABAKOFF DAVID S has filed insider reports for
- NextCure, Inc. (NXTC): Director
KABAKOFF DAVID S
CIK: 0001024008
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NXTC
NextCure, Inc.
Director